David J. Sher

8.3k total citations · 1 hit paper
238 papers, 5.2k citations indexed

About

David J. Sher is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiation. According to data from OpenAlex, David J. Sher has authored 238 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Pulmonary and Respiratory Medicine, 107 papers in Otorhinolaryngology and 66 papers in Radiation. Recurrent topics in David J. Sher's work include Head and Neck Cancer Studies (107 papers), Advanced Radiotherapy Techniques (66 papers) and Lung Cancer Diagnosis and Treatment (63 papers). David J. Sher is often cited by papers focused on Head and Neck Cancer Studies (107 papers), Advanced Radiotherapy Techniques (66 papers) and Lung Cancer Diagnosis and Treatment (63 papers). David J. Sher collaborates with scholars based in United States, China and Canada. David J. Sher's co-authors include Matthew Koshy, Rinaa S. Punglia, Roy B. Tishler, Howard E. Morgan, Chul Ahn, Aileen B. Chen, Saad A. Khan, Chad G. Rusthoven, Bernard L. Jones and Baran D. Sumer and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David J. Sher

220 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline

2019 223 citations David J. Sher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Sher United States	41	2.2k	1.5k	1.4k	1.2k	1.2k	238	5.2k
Soon Yuhl Nam South Korea	45	1.3k 0.6×	1.9k 1.3×	2.3k 1.6×	1.1k 0.9×	2.9k 2.4×	243	5.9k
Yolanda Barbáchano United Kingdom	25	1.2k 0.5×	2.0k 1.4×	212 0.1×	436 0.4×	1.4k 1.2×	57	3.4k
David Joseph Australia	46	3.3k 1.5×	3.3k 2.2×	98 0.1×	1.0k 0.8×	1.1k 0.9×	183	7.3k
Mark F. Berry United States	40	3.3k 1.5×	1.2k 0.8×	149 0.1×	478 0.4×	1.6k 1.3×	178	4.8k
Isildinha M. Reis United States	33	641 0.3×	1.5k 1.0×	159 0.1×	359 0.3×	527 0.4×	180	3.6k
Ralph P. Tufano United States	56	1.0k 0.5×	1.1k 0.8×	926 0.6×	748 0.6×	7.5k 6.2×	299	10.8k
Nofisat Ismaila United States	31	1.9k 0.8×	2.1k 1.4×	612 0.4×	539 0.4×	838 0.7×	76	4.4k
Changhong Yu United States	33	1.6k 0.7×	539 0.4×	118 0.1×	225 0.2×	760 0.6×	99	3.3k
John R. de Almeida Canada	34	650 0.3×	937 0.6×	1.9k 1.3×	205 0.2×	2.6k 2.2×	227	4.4k
Oke Gerke Denmark	31	1.2k 0.5×	448 0.3×	173 0.1×	1.8k 1.5×	956 0.8×	301	4.3k

Countries citing papers authored by David J. Sher

Since Specialization

Citations

This map shows the geographic impact of David J. Sher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Sher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Sher more than expected).

Fields of papers citing papers by David J. Sher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Sher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Sher. The network helps show where David J. Sher may publish in the future.

Co-authorship network of co-authors of David J. Sher

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Sher. A scholar is included among the top collaborators of David J. Sher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Sher. David J. Sher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sher, David J., Vladimir Avkshtol, Mu‐Han Lin, et al.. (2025). Impact of daily adaptive head and neck radiotherapy on toxicity and quality of life: results of the DARTBOARD phase II randomized trial. JNCI Journal of the National Cancer Institute. 117(12). 2488–2494. 1 indexed citations

Rahman, Mahbubur, Zohaib Iqbal, David Parsons, et al.. (2024). Mitigating Risks in Cone Beam Computed Tomography Guided Online Adaptive Radiation Therapy: A Preventative Reference Planning Review Approach. Advances in Radiation Oncology. 9(11). 101614–101614. 2 indexed citations

Chen, Xuguang, David J. Sher, Christopher Blake Sullivan, et al.. (2024). Target Delineation in Postoperative Radiation Therapy for Head and Neck Cancer After Flap Reconstruction. Practical Radiation Oncology. 14(4). 328–333. 1 indexed citations

Bonomi, Marcelo, David J. Sher, Rafi Kabarriti, et al.. (2024). RRx-001 Affects Multiple Toxicities in Patients Receiving Concomitant Chemoradiation for Head and Neck Cancers: Observations of the PREVLAR Phase II Trial. 1 indexed citations

Dohopolski, Michael, Kevin Diao, Katherine A. Hutcheson, et al.. (2023). Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. JAMA Otolaryngology–Head & Neck Surgery. 149(8). 697–697. 3 indexed citations

Isaacson, Brandon, et al.. (2023). Five-Fraction Stereotactic Radiation for Head and Neck Paragangliomas. International Journal of Radiation Oncology*Biology*Physics. 117(2). e183–e184. 2 indexed citations

Kuhn, Maggie A., M. Boyd Gillespie, Stacey L. Ishman, et al.. (2023). Expert Consensus Statement: Management of Dysphagia in Head and Neck Cancer Patients. Otolaryngology. 168(4). 571–592. 28 indexed citations

Sher, David J., Dominic H. Moon, Dat T. Vo, et al.. (2023). Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical Trial. Clinical Cancer Research. 29(17). 3284–3291. 13 indexed citations

Avkshtol, Vladimir, et al.. (2023). Early Experience of Online Adaptive Radiation Therapy for Definitive Radiation of Patients With Head and Neck Cancer. Advances in Radiation Oncology. 8(5). 101256–101256. 19 indexed citations

10.

Parsons, David, Dominic H. Moon, Vladimir Avkshtol, et al.. (2023). Evaluating machine learning enhanced intelligent‐optimization‐engine (IOE) performance for ethos head‐and‐neck (HN) plan generation. Journal of Applied Clinical Medical Physics. 24(7). e13950–e13950. 18 indexed citations

11.

Sher, David J., Vladimir Avkshtol, Dominic H. Moon, et al.. (2021). Recurrence and Quality-of-Life Following Involved Node Radiotherapy for Head and Neck Squamous Cell Carcinoma: Initial Results From the Phase II INRT-Air Trial. International Journal of Radiation Oncology*Biology*Physics. 111(3). e398–e398. 5 indexed citations

12.

Moore, William, Dominic H. Moon, Vladimir Avkshtol, et al.. (2021). Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy. Oral Oncology. 123. 105623–105623. 1 indexed citations

13.

Sher, David J., Marcelo Bonomi, Dukagjin Blakaj, et al.. (2020). Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx Squamous Cell Carcinoma (OSCC). International Journal of Radiation Oncology*Biology*Physics. 108(3). S107–S108. 3 indexed citations

14.

Chen, Liyuan, Zhiguo Zhou, David J. Sher, et al.. (2019). Combining many-objective radiomics and 3D convolutional neural network through evidential reasoning to predict lymph node metastasis in head and neck cancer. Physics in Medicine and Biology. 64(7). 75011–75011. 83 indexed citations

15.

Foster, Corey C., David J. Sher, Chad G. Rusthoven, et al.. (2019). Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis. Radiation Oncology. 14(1). 18–18. 38 indexed citations

16.

Sanford, Nina N., David J. Sher, Santino Butler, et al.. (2019). Prevalence of chronic pain among cancer survivors in the United States, 2010‐2017. Cancer. 125(23). 4310–4318. 46 indexed citations

17.

Koshy, Matthew, David J. Sher, Michael T. Spiotto, et al.. (2014). The Effect of Radiotherapy Dose on Survival in Stage III Non–Small-Cell Lung Cancer Patients Undergoing Definitive Chemoradiotherapy. Clinical Lung Cancer. 15(5). 365–371. 9 indexed citations

18.

Lester-Coll, N.H., Samuel Z. Goldhaber, David J. Sher, & Anthony V. D’Amico. (2013). Death from high‐risk prostate cancer versus cardiovascular mortality with hormonal therapy. Cancer. 119(10). 1808–1815. 24 indexed citations

19.

Aristophanous, Michalis, Ross Berbeco, Joseph H. Killoran, et al.. (2011). Clinical Utility of 4D FDG-PET/CT Scans in Radiation Treatment Planning. International Journal of Radiation Oncology*Biology*Physics. 82(1). e99–e105. 73 indexed citations

20.

Sher, David J., Eve Wittenberg, & Rinaa S. Punglia. (2007). Partial-Breast Irradiation Versus Whole-Breast Irradiation for Early-Stage Breast Cancer: A Decision Analysis. International Journal of Radiation Oncology*Biology*Physics. 69(3). S92–S92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact